Provided by Tiger Fintech (Singapore) Pte. Ltd.

Third Harmonic Bio, Inc.

5.38
0.0000
Volume:- -
Turnover:- -
Market Cap:242.79M
PE:-4.32
High:5.38
Open:5.38
Low:5.38
Close:5.38
52wk High:16.02
52wk Low:3.18
Shares:45.13M
Float Shares:15.60M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2457
EPS(LYR):-1.0896
ROE:-19.94%
ROA:-14.60%
PB:0.89
PE(LYR):-4.94

Loading ...

Company Profile

Company Name:
Third Harmonic Bio, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.